Several studies have proved that γ-secretase inhibitors and all-trans retinoic acid (ATRA) could upregulate BCMA expression on MM cells and facilitate their recognition by anti-BCMA CAR-T cells (40, 41). This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.